News

Michael Albert, 17, helped ID a potential drug target to treat acute myeloid leukemia

2016 Apr 25

Teenager helps ID new target for aggressive leukemia

Michael Albert, 17, has worked with the lab of Monica Guzman, Ph.D., to identify ephrin receptors as potential therapeutic targets for acute myeloid leukemia. Read more

2016 Apr 25

Drug developed for lymphoma could provide hope for lung cancer patients

The lab of Leandro Cerchietti, M.D., has revealed early evidence that a BCL6 inhibitor initially studied as a potential B-cell lymphoma treatment might also be effective against chemo-resistant non-small cell lung cancers. Read more

2016 Apr 21

Questions on PD-L1 Diagnostics for Immunotherapy in NSCLC

Brendon Stiles, M.D., comments on the immunotherapies available to treat non-small cell lung cancer. Read more

Gastrointestinal oncologist Allyson Ocean of the Meyer Cancer Center

2016 Apr 21

10 Things Cancer Experts Do To Avoid Getting The Disease

Allyson Ocean, M.D., shares some pointers with Prevention Magazine. Read more

2016 Apr 20

Copper depletion may reduce breast cancer relapse in patients at high risk

Linda Vahdat, M.D., shares results of studies into copper depletion as a potential therapy for triple-negative breast cancer. Read more

Juan Cubillos-Ruiz and Dan Landau with Sonequa Martin-Green

2016 Apr 19

Hollywood star honors star Meyer researchers

Weill Cornell Medicine researchers Juan Cubillos-Ruiz, Ph.D., and Dan Landau, M.D., Ph.D., were two of 10 young investigators nationwide who received Innovative Research Grants from Stand Up To Cancer. Read more

2016 Apr 19

Computer to clinic: Tool developed at Weill predicts drug success

A computational tool created by a graduate student in the lab of Olivier Elemento, Ph.D, has realized its first clinical application - less than a year after its development. Read more

2016 Apr 18

First-in-class antibody-drug conjugate shows promising preliminary results for metastatic platinum-resistant urothelial cancer

Scott Tagawa, M.D., M.S., discusses the results of a phase I/II trial into a promising new immunotherapy drug for bladder cancer. Read more

Photo of Drs. Rubin, Sboner, Beltran and Elemento

2016 Apr 17

Englander Institute joins international genomic medicine effort

Tumors sequenced at Weill Cornell Medicine/NewYork-Presbyterian could help further cancer research across the globe, as part of the International Cancer Genome Consortium Read more

2016 Apr 15

Panoply of new agents, complete remission rates mark ‘special day’ in myeloma

Ruben Niesvizky, M.D., discusses the “privilege” of caring for patients with myeloma in an era of therapeutic milestones. Read more

Silvia Formenti, M.D., is pioneering the use of radiation for immunotherapy in cancer

2016 Apr 15

The promise of combining radiotherapy and immunotherapy to treat cancer

Silvia Formenti, M.D., discusses her novel approach to immunotherapy using radiation treatment. Read more

Ekta Khurana, Ph.D., assistant professor of computational biology at the Meyer Cancer Center, Weill Cornell Medicine

2016 Apr 14

Cancer genomics: Hard-to-reach repairs

Ekta Khurana, Ph.D., comments on two studies about DNA repair mechanisms. Read more

Doctors at Meyer Cancer Center are enrolling cancer patients in immunotherapy trials

2016 Apr 13

Lymphoma researchers earn Top 10 Clinical Research Award

The lymphoma clinical research group has received a Clinical Research Forum award for its study demonstrating the efficacy of an innovative combination therapy for treating mantle cell lymphoma. Read more

2016 Apr 13

Unraveling how obesity fuels cancer

Andrew Dannenberg, M.D., discusses the effect of inflammation and aromatase expression on breast cancer risk. Read more

2016 Apr 11

A Pathway to Success: Studying signal transduction in cancer and other diseases

Lewis Cantley, Ph.D., discusses his career in science Read more

2016 Apr 08

Scientists push to expand survival rates for brain cancer patients

One size does not fit all for brain cancer treatment, says Howard Fine, M.D. Read more

2016 Apr 08

The transformation of oncology

We are living in a remarkable time for cancer research - let's take advantage of it, says Harold Varmus, M.D., Read more

Marcin Imielinski, M.D., Ph.D., computational biologist at Meyer Cancer Center, Weill Cornell Medicine

2016 Apr 08

A career in cancer research? Computational skills wanted

Marcin Imielinski, M.D., Ph.D., and Mark Rubin, M.D., discuss burgeoning career options in cancer research. Read more

2016 Apr 06

Cancer metastases: Are one and all the same?

Himisha Beltran, M.D., comments on a study on prostate cancer pathogenesis and metastasis. Read more

2016 Apr 06

Most cancer patients have overly optimistic view of their life expectancy

Most patients have an overly optimistic view of their life expectancy and that few patients base their estimate on communications with their healthcare providers, said Holly Prigerson, Ph.D. Read more

News

Teenager helps ID new target for aggressive leukemia

Drug developed for lymphoma could provide hope for lung cancer patients

Questions on PD-L1 Diagnostics for Immunotherapy in NSCLC

10 Things Cancer Experts Do To Avoid Getting The Disease

Copper depletion may reduce breast cancer relapse in patients at high risk

Hollywood star honors star Meyer researchers

Computer to clinic: Tool developed at Weill predicts drug success

First-in-class antibody-drug conjugate shows promising preliminary results for metastatic platinum-resistant urothelial cancer

Englander Institute joins international genomic medicine effort

Panoply of new agents, complete remission rates mark ‘special day’ in myeloma

The promise of combining radiotherapy and immunotherapy to treat cancer

Cancer genomics: Hard-to-reach repairs

Lymphoma researchers earn Top 10 Clinical Research Award

Unraveling how obesity fuels cancer

A Pathway to Success: Studying signal transduction in cancer and other diseases

Scientists push to expand survival rates for brain cancer patients

The transformation of oncology

A career in cancer research? Computational skills wanted

Cancer metastases: Are one and all the same?

Most cancer patients have overly optimistic view of their life expectancy

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters